
Robert Schierwagen
Sigmund Freud Str 25
Bonn, NW 53127, Germany
Bonn, NW 53127, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications
Multidisciplinary Delphi consensus statement on minimal standards for clinical metadata and end points in microbiome studies.
Journal: Nature reviews. Gastroenterology & hepatology
Published: July 02, 2026
Posttranscriptional reprogramming controls MASLD progression through chronic ER stress adaptation.
Journal: Science advances
Published: April 03, 2026
Erratum: Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure.
Journal: Hepatology (Baltimore, Md.)
Published: November 03, 2025
Metabolic Signatures of Acinetobacter baumannii and Klebsiella pneumoniae Infections in Acute-on-chronic Liver Failure.
Journal: Cellular and molecular gastroenterology and hepatology
Published: August 22, 2025
CRISPR/Cas9-mediated gene correction of Wilson disease H1069Q point mutation in patient-specific induced pluripotent stem cells.
Journal: Gene therapy
Published: April 09, 2025
L actococcus A phages predict ACLF while Enterococcus B phages predict bacterial infection in decompensated cirrhosis.
Journal: JHEP reports : innovation in hepatology
Published: April 03, 2025
Higher prevalence of cytomegalovirus and Epstein-Barr virus in acute-on-chronic liver failure.
Journal: JHEP reports : innovation in hepatology
Published: March 20, 2025
Hepatocellular Cancer Surveillance in Patients with Advanced Chronic Liver Disease.
Journal: NEJM evidence
Published: October 22, 2024
Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis.
Journal: Gut
Published: September 16, 2024
Decompensated MASH-Cirrhosis Model by Acute and Toxic Effects of Phenobarbital.
Journal: Cells
Published: July 23, 2024
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial.
Journal: Nature communications
Published: May 04, 2024
Last Updated: 09/26/2026